{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:27:24Z","timestamp":1759667244859},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s12272-011-1111-2","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T10:40:01Z","timestamp":1322908801000},"page":"1909-1917","source":"Crossref","is-referenced-by-count":14,"title":["Preparation and characterization of emulsified solid dispersions containing docetaxel"],"prefix":"10.1007","volume":"34","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongzhi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,3]]},"reference":[{"key":"1111_CR1","first-page":"6158","volume":"62","author":"H. A. Bardelmeijer","year":"2002","unstructured":"Bardelmeijer, H. A., Ouwehand, M., Buckle, T., Huisman, M. T., Schellens, J. H., Beijnen, J. H., and van Tellingen, O., Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir. Cancer Res., 62, 6158\u20136164 (2002).","journal-title":"Cancer Res."},{"issue":"Suppl4","key":"1111_CR2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0959-8049(95)00357-O","volume":"31A","author":"M. C. Bissery","year":"1995","unstructured":"Bissery, M. C., Preclinical pharmacology of docetaxel. Eur. J. Cancer, 31ASuppl 4, S1\u2013S6 (1995).","journal-title":"Eur. J. Cancer"},{"key":"1111_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpharm.2010.01.039","volume":"390","author":"H. Bley","year":"2010","unstructured":"Bley, H., Fussnegger, B., and Bodmeier, R., Characterization and stability of solid dispersions based on PEG\/polymer blends. Int. J. Pharm., 390, 165\u2013173 (2010).","journal-title":"Int. J. Pharm."},{"key":"1111_CR4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/03639040701831835","volume":"34","author":"J. Chen","year":"2008","unstructured":"Chen, J., Qiu, L., Hu, M., Jin, Y., and Han, J., Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel. Drug Dev. Ind. Pharm., 34, 588\u2013594 (2008).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"1111_CR5","first-page":"1507","volume":"12","author":"Y. Chen","year":"2009","unstructured":"Chen, Y., Chen, G., Shi, Q. Z., Yu, A. R., Fu, X. D., and Liu, H., Study on self-microemulsifying drug delivery system of docetaxel. China Pharmacist, 12, 1507\u20131510 (2009).","journal-title":"China Pharmacist"},{"key":"1111_CR6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003088-199936020-00002","volume":"36","author":"S. J. Clarke","year":"1999","unstructured":"Clarke, S. J. and Rivory, L. P., Clinical pharmacokinetics of docetaxel. Clin. Pharmacokinet., 36, 99\u2013114 (1999).","journal-title":"Clin. Pharmacokinet."},{"key":"1111_CR7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2006.11.059","volume":"333","author":"S. Conti","year":"2007","unstructured":"Conti, S., Maggi, L., Segale, L., Ochoa Machiste, E., Conte, U., Grenier, P., and Vergnault, G., Matrices containing NaCMC and HPMC 1. Dissolution performance characterization. Int. J. Pharm., 333, 136\u2013142 (2007).","journal-title":"Int. J. Pharm."},{"key":"1111_CR8","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/mp8000793","volume":"5","author":"D. T. Friesen","year":"2008","unstructured":"Friesen, D. T., Shanker, R., Crew, M., Smithey, D. T., Curatolo, W. J., and Nightingale, J. A., Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol. Pharm., 5, 1003\u20131019 (2008).","journal-title":"Mol. Pharm."},{"key":"1111_CR9","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/jps.10511","volume":"92","author":"P. Gao","year":"2003","unstructured":"Gao, P., Rush, B. D., Pfund, W. P., Huang, T., Bauer, J. M., Morozowich, W., Kuo, M. S., and Hageman, M. J., Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J. Pharm. Sci., 92, 2386\u20132398 (2003).","journal-title":"J. Pharm. Sci."},{"key":"1111_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1081\/DDC-120028718","volume":"30","author":"P. Gao","year":"2004","unstructured":"Gao, P., Guyton, M. E., Huang, T., Bauer, J. M., Stefanski, K. J., and Lu, Q., Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev. Ind. Pharm., 30, 221\u2013229 (2004).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"1111_CR11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/BF02977766","volume":"28","author":"M. Y. Heo","year":"2005","unstructured":"Heo, M. Y., Piao, Z. Z., Kim, T. W., Cao, Q. R., Kim, A., and Lee, B. J., Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole. Arch. Pharm. Res., 28, 604\u2013611 (2005).","journal-title":"Arch. Pharm. Res."},{"key":"1111_CR12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-3659(03)00271-2","volume":"91","author":"M. L. Immordino","year":"2003","unstructured":"Immordino, M. L., Brusa, P., Arpicco, S., Stella, B., Dosio, F., and Cattel, L., Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J. Control. Release, 91, 417\u2013429 (2003).","journal-title":"J. Control. Release"},{"key":"1111_CR13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejpb.2008.05.025","volume":"70","author":"S. Janssens","year":"2008","unstructured":"Janssens, S., Humbeeck, J. V., and Van den Mooter, G., Evaluation of the formulation of solid dispersions by cospray drying itraconazole with Inutec SP1, a polymeric surfactant, in combination with PVPVA 64. Eur. J. Pharm. Biopharm., 70, 500\u2013505 (2008).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"1111_CR14","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1211\/jpp.61.12.0001","volume":"61","author":"S. Janssens","year":"2009","unstructured":"Janssens, S. and Van den Mooter, G., Review: physical chemistry of solid dispersions. J. Pharm. Pharmacol., 61, 1571\u20131586 (2009).","journal-title":"J. Pharm. Pharmacol."},{"key":"1111_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2003.09.002","volume":"269","author":"H. N. Joshi","year":"2004","unstructured":"Joshi, H. N., Tejwani, R. W., Davidovich, M., Sahasrabudhe, V. P., Jemal, M., Bathala, M. S., Varia, S. A., and Serajuddin, A. T., Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int. J. Pharm., 269, 251\u2013258 (2004).","journal-title":"Int. J. Pharm."},{"key":"1111_CR16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/10837450903085400","volume":"15","author":"M. C. Lamas","year":"2010","unstructured":"Lamas, M. C., Leonardi, D., Lambri, O. A., Bassani, G., Barrera, M. G., Bolmaro, R. E., and Salomon, C. J., Preparation, characterization and dissolution studies of fast release diclofenac sodium tablets from PVP solid dispersions. Pharm. Dev. Technol., 15, 162\u2013168 (2010).","journal-title":"Pharm. Dev. Technol."},{"key":"1111_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","volume":"50","author":"C. Leuner","year":"2000","unstructured":"Leuner, C. and Dressman, J., Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm., 50, 47\u201360 (2000).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"1111_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1248\/bpb.33.279","volume":"33","author":"D. X. Li","year":"2010","unstructured":"Li, D. X., Jang, K. Y., Kang, W., Bae, K., Lee, M. H., Oh, Y. K., Jee, J. P., Park, Y. J., Oh, D. H., Seo, Y. G., Kim, Y. R., Kim, J. O., Woo, J. S., Yong, C. S., and Choi, H. G., Enhanced solubility and bioavailability of sibutramine base by solid dispersion system with aqueous medium. Biol. Pharm. Bull., 33, 279\u2013284 (2010).","journal-title":"Biol. Pharm. Bull."},{"key":"1111_CR19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2001.19.4.1160","volume":"19","author":"M. M. Malingr\u00e9","year":"2001","unstructured":"Malingr\u00e9, M. M., Richel, D. J., Beijnen, J. H., Rosing, H., Koopman, F. J., Ten Bokkel Huinink, W. W., Schot, M. E., and Schellens, J. H., Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel. J. Clin. Oncol., 19, 1160\u20131166 (2001).","journal-title":"J. Clin. Oncol."},{"key":"1111_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00520-002-0405-9","volume":"11","author":"M. Markman","year":"2003","unstructured":"Markman, M., Managing taxane toxicities. Support Care Cancer, 11, 144\u2013147 (2003).","journal-title":"Support Care Cancer"},{"key":"1111_CR21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/0250-474X.57290","volume":"71","author":"A. Mesnukul","year":"2009","unstructured":"Mesnukul, A., Yodkhum, K., and Phaechamud, T., Solid Dispersion Matrix Tablet Comprising Indomethacin-PEGHPMC Fabricated with Fusion and Mold Technique. Indian J. Pharm. Sci., 71, 413\u2013420 (2009).","journal-title":"Indian J. Pharm. Sci."},{"key":"1111_CR22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2009.10.001","volume":"384","author":"S. Muela","year":"2010","unstructured":"Muela, S., Escalera, B., Pe\u00f1a, M. A., and Bustamante, P., Influence of temperature on the solubilization of thiabendazole by combined action of solid dispersions and cosolvents. Int. J. Pharm., 384, 93\u201399 (2010).","journal-title":"Int. J. Pharm."},{"key":"1111_CR23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2006.06.023","volume":"325","author":"T. Musumeci","year":"2006","unstructured":"Musumeci, T., Ventura, C. A., Giannone, I., Ruozi, B., Montenegro, L., Pignatello, R., and Puglisi, G., PLA\/PLGA nanoparticles for sustained release of docetaxel. Int. J. Pharm., 325, 172\u2013179 (2006).","journal-title":"Int. J. Pharm."},{"key":"1111_CR24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2165\/00044011-199714050-00011","volume":"14","author":"P. R. Nannan","year":"1997","unstructured":"Nannan P. R. and Huizing, M. T., Hypersensitivity reactions to the taxanes paclitaxel and docetaxel. Clin. Drug Investing, 14, 418\u2013427 (1997).","journal-title":"Clin. Drug Investing"},{"key":"1111_CR25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1010682916808","volume":"19","author":"B. Nuijen","year":"2001","unstructured":"Nuijen, B., Bouma, M., Schellens, J. H., and Beijnen, J. H., Progress in the development of alternative pharmaceutical formulations of taxanes. Invest. New Drugs, 19, 143\u2013153 (2001).","journal-title":"Invest. New Drugs"},{"issue":"Suppl2","key":"1111_CR26","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","volume":"11","author":"C. W. Pouton","year":"2000","unstructured":"Pouton, C. W., Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2019self-microemulsifying\u2019 drug delivery systems. Eur. J. Pharm. Sci., 11Suppl 2, S93\u2013S98 (2000).","journal-title":"Eur. J. Pharm. Sci."},{"key":"1111_CR27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0378-5173(00)00610-4","volume":"212","author":"S. L. Raghavan","year":"2001","unstructured":"Raghavan, S. L., Trividic, A., Davis, A. F., and Hadgraft, J., Crystallization of hydrocortisone acetate: influence of polymers. Int. J. Pharm., 212, 213\u2013221 (2001).","journal-title":"Int. J. Pharm."},{"key":"1111_CR28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jnci\/83.4.288","volume":"83","author":"I. Ringel","year":"1991","unstructured":"Ringel, I. and Horwitz, S. B., Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J. Natl. Cancer Inst., 83, 288\u2013291 (1991).","journal-title":"J. Natl. Cancer Inst."},{"key":"1111_CR29","first-page":"227","volume":"64","author":"P. P. Sancheti","year":"2009","unstructured":"Sancheti, P. P., Karekar, P., Vyas, V. M., Shah, M., and Pore, Y. V., Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe. Pharmazie, 64, 227\u2013231 (2009).","journal-title":"Pharmazie"},{"key":"1111_CR30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00280-004-0826-x","volume":"54","author":"N. Takigawa","year":"2004","unstructured":"Takigawa, N., Segawa, Y., Kishino, D., Fujiwara, K., Tokuda, Y., Seki, N., Shinkai, T., Watanabe, Y., Hiraki, S., Kozuki, T., Gemba, K., Tabata, M., Kiura, K., Ueoka, H., and Tanimoto, M., Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients. Cancer Chemother. Pharmacol., 54, 230\u2013236 (2004).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1111_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9020-z","volume":"94","author":"Y. L. Tham","year":"2005","unstructured":"Tham, Y. L., Gomez, L. F., Mohsin, S., Gutierrez, M. C., Weiss, H., Hilsenbeck, S. G., Elledge, R. M., Chamness, G. C., Osborne, C. K., Allred, D. C., and Chang, J. C., Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers. Breast Cancer Res. Treat., 94, 279\u2013284 (2005).","journal-title":"Breast Cancer Res. Treat."},{"key":"1111_CR32","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.drudis.2007.09.005","volume":"12","author":"T. Vasconcelos","year":"2007","unstructured":"Vasconcelos, T., Sarmento, B., and Costa, P., Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today, 12, 1068\u20131075 (2007).","journal-title":"Drug Discov. Today"},{"key":"1111_CR33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0168-3659(98)00110-2","volume":"57","author":"M. V. Velasco","year":"1999","unstructured":"Velasco, M. V., Ford, J. L., and Rowe, P., Rajabi-Siahboomi AR. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J. Control. Release, 57, 75\u201385 (1999).","journal-title":"J. Control. Release"},{"key":"1111_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijpharm.2004.11.020","volume":"290","author":"Y. Yokoi","year":"2005","unstructured":"Yokoi, Y., Yonemochi, E., and Terada, K., Effects of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension. Int. J. Pharm., 290, 91\u201399 (2005).","journal-title":"Int. J. Pharm."},{"key":"1111_CR35","first-page":"654","volume":"63","author":"A. Zaghloul","year":"2008","unstructured":"Zaghloul, A., Khattab, I., Nada, A., and Al-Saidan, S., Preparation, characterization and optimization of probucol self-emulsified drug delivery system to enhance solubility and dissolution. Pharmazie, 63, 654\u2013660 (2008).","journal-title":"Pharmazie"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-011-1111-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-011-1111-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-011-1111-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T05:06:14Z","timestamp":1593320774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-011-1111-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1111"],"URL":"https:\/\/doi.org\/10.1007\/s12272-011-1111-2","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}